Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland ; volume:5 ; number:1 ; day:9 ; month:4 ; year:2018 ; pages:57-73 ; date:6.2018
Rheumatology and therapy ; 5, Heft 1 (9.4.2018), 57-73, 6.2018
- Urheber
-
Borse, Rebekah H.
- Beteiligte Personen und Organisationen
-
Kachroo, Sumesh
Brown, Chloe
McCann, Eilish
Insinga, Ralph P.
SpringerLink (Online service)
- DOI
-
10.1007/s40744-018-0108-4
- URN
-
urn:nbn:de:101:1-2018070801270653611835
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borse, Rebekah H.
- Kachroo, Sumesh
- Brown, Chloe
- McCann, Eilish
- Insinga, Ralph P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
P190: Cardiovascular Disease in Axial Spondyloarthritis
Targeting inflammatory pathways in axial spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
P190: Cardiovascular Disease in Axial Spondyloarthritis
Targeting inflammatory pathways in axial spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
P190: Cardiovascular Disease in Axial Spondyloarthritis